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Abstract
Introduction: Immunofluorescence (IF) microscopy 
is an important tool for the diagnosis of glomerular 
diseases. In this study, we focused on using IF technique 
together with light microscopy (LM) and clinical features 
in the diagnosis of different types of glomerulonephritis 
(GN). We aimed to evaluate the spectrum of glomerular 
diseases in our center and compare it with other centers 
in Iraq as well as in other countries.
Methods: We studied a total of 58 kidney biopsies taken 
between June 2010 and June 2012. All biopsies were 
examined by LM and 56 of them were examined by IF 
technique. Clinical information was recorded in a pre-
designed form before taking the biopsy.
Results: Nephrotic syndrome was the predominant 
clinical presentation in this study (75.9%). Focal segmental 
glomerulosclerosis (FSGS) was the commonest GN in 
this study (29.3%) followed by minimal change disease 
(20.7%) and membranous glomerulonephritis (13.8%). 
Immune deposition was observed in 37.5% of cases and 
the predominant deposit was immunoglobulin G (IgG). 
In all cases but one, deposition was granular and was 
found in the glomerular basement membrane (GBM) and/
or in the mesangium. In one case, IF showed dominant 
positive staining (3+) for complement factor 1q (C1q) in 
the glomerular mesangium and slightly positive staining 
for complement factor 3 (C3) in the same mesangeal 
areas. Two cases (3.4%) fulfilled the clinical, serological 
and histopathological criteria of lupus nephritis (LN).
Conclusion: Nephrotic syndrome was the predominant 
clinical presentation and FSGS was the most commonly 
diagnosed GN in this study. Using IF technique and 
correlating it with LM, clinical, biochemical and 
serological markers was very useful for the correct 
diagnosis of glomerular diseases.
Keywords: Glomerulonephritis; Immunofluorescence; 
Iraq; Renal Biopsy.
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Introduction
Glomerular disorders constitute one of the major causes 
of morbidity and mortality [1]. Immune mechanisms are 
responsible for glomerular injury in most cases of primary 
glomerulonephritis (GN) and many of the secondary GN 
[2]. Accurate diagnosis of GN requires renal biopsy and 
histopathological examination by light microscopy (LM), 
immunofluorescence (IF) and electron microscopy (EM). 
In addition, it requires correlating clinical features and 
biochemical parameters with histopathology results [4]. 
IF microscopy provides insight into the pathogenesis of 
glomerular diseases and it is very useful in diagnosing 
primary renal diseases and assessing the nature and 
severity of renal involvement in various systemic 
disorders. In addition, IF yields important correlations 
and prognostic features [3].  
Facilities for EM studies are not readily available in 
many institutions. In most cases, LM and IF studies are 
satisfactory for the definitive diagnosis of GN [4]. For 
instance, in stage-1 of membranous GN (MGN) there is 
no thickening of the glomerular basement (GBM) and no 
spikes on silver stain, and so it may not be distinguished 
from minimal change disease (MCD) by LM [5]. IF 
reveals the fine granular deposition of immunoglobulin 
and complement and confirms the diagnosis of MGN, at 
the same time distinguishing it from anti-GBM nephritis 
where liner deposits in IF and anti-GBM antibodies in 
serum are seen [5, 6]. Lupus nephritis (LN) patients 
of WHO class-V show immunohistological features 
of primary MGN similar to hepatitis B virus related 
nephropathy. At the time of biopsy, when systemic 
lupus erythematosus (SLE) is clinically suspected, the 
differentiation between hepatitis B virus related MGN 
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and LN may be difficult or impossible [7-9]. Although 
sub-endothelial and mesangial prominent IgA deposits 
are suggestive and only tubular basement membrane 
deposits are specific, correct diagnosis of LN can be made 
by correlating typical clinical features and serological 
markers [5]. Hepatitis B infection may be occult, serum 
transaminases may be normal and there may be no history 
of clinical hepatitis. The study of glomerular viral antigens 
and serological screening are important for the diagnosis 
of hepatitis B virus-related nephritis [9]. C1q is the first 
component of the classical pathway of complement 
activation. C1q nephropathy is a clinical condition 
characterized by onset in older children and young adults 
with severe proteinuria or nephrotic syndrome, with 
resistance to steroid treatment, frequent recurrence and 
a poor long-term prognosis. Asymptomatic hematuria 
and/or proteinuria are also seen in C1q nephropathy [10, 
11]. Together with the deposition of C1q, deposition of 
immunoglobulin is often detected in glomeruli in C1q 
nephropathy.
In this study, different types of GN were diagnosed 
using LM and IF together with interpretation of clinical, 
biochemical and serological features. The spectrum 
of glomerular disease in our center was determined 
and compared with other studies in Iraq and in other 
countries.
Methods
This study was carried out at the Iraqi medical center 
in Karbala. A total of 58 cases of nephrotic syndrome, 
nephritic syndrome, kidney grafts, asymptomatic 
hematuria and proteinuria in various age groups were 
biopsied and included in this study. The study period 
was from June 2010 to June 2012. Clinical information 
was recorded in a pre-designed form before taking the 
biopsy. All kidney biopsies were performed by the first 
author after obtaining signed informed consent. At least 
two specimens of renal tissue measuring 12-20 mm in 
length were taken per biopsy. One specimen was kept in 
10% formalin for LM study and another one in transport 
media of Zeus solution for IF study. Specimens were 
kept in an ice bag and sent to the laboratory where the 
formalin-fixed processed tissue sections were stained by 
hematoxylin-eosin, reticulin, silver methnamine, congo 
red and Periodic Acid Schiff (PAS) stains. The specimens 
were then examined by LM and IF and verified by at least 
two histopathologists.
The following criteria were used to define different 
terms and various patterns of GN; adequate for IF study: 
presence of at least one glomerulus under fluorescent 
microscope; adequate for light microscopic study: 
presence of at least five glomeruli under LM; mesangial 
proliferation: more than three mesangial cells embedded 
in matrix of one segment; endothelial proliferation: more 
than 2 nuclei per capillary loop; leukocyte infiltration: 
more than five leukocytes per glomerulus; crescentic 
GN: at least 50% of the glomeruli involved as crescents; 
MCD: no evidence of any change; FSGS: segmental 
(one or two lobules) sclerosis with hyalinosis involving 
portions of fewer than 50% of the glomeruli in a section; 
sclerosis: increase in amount of homogeneous non-
fibrillary extracellular material of similar composition 
to GBM and mesangium; MGN: diffuse thickening of 
GBM due to sub-epithelial deposits of immune complex 
without evidence of inflammation or cellular proliferation; 
membrano-proliferative GN (MPGN): diffuse thickening 
of GBM with predominant proliferation of mesangial 
cells and extension of matrix often with interposition 
in between the endothelial cells and GBM, causing 
tram-track appearance under LM; mesangio-proliferative 
GN (MesPGN): diffuse increase in glomerular cellularity 
predominantly due to mesangial cells often with 
concomitant increase in mesangial matrix. Systemic 
lupus erythematosus (SLE) was diagnosed according to 
the criteria of the American College of Rheumatology 
[12].
Photographs were taken for both LM and IF studies. 
Fluorescein dye conjugated anti-human antibodies (lgG, 
IgA, IgM, C1q, fibrin and C3) were fixed with the tissue 
section by ten times diluted anti-sera. Type (lgG, IgA, 
IgM ,C1q, fibrin and C3), pattern (granular or linear), 
site (GBM or mesangium) and intensity of deposition 
in the glomeruli were observed under IF. The intensity 
of fluorescein isothiocyanate staining was graded 
subjectively from 0 to +3. Clinical information regarding 
age, sex, duration of disease, presentation, urine analysis, 
biochemical, virological and serological parameters and 
past medical therapy were collected from data submitted 
along with biopsy.
Results
The study involved biopsies taken from 58 patients, 
including 30 males (51.7%) and 28 (48.3%) females. 
Their ages ranged from 6-50 years (mean=26 years). 
Table-1 shows the clinical presentation of GN in this 
study. The commonest presentation was nephrotic 
syndrome (75.9 %) followed by proteinuria (36.8 %) and 
systemic hypertension (29.3 %). 
Definitive diagnosis was possible in all cases as all 
specimens were considered adequate. FSGS was the 
commonest GN in this study (29.3%) followed by MCD 
(20.7%) and MGN (13.8%) as shown in table-2.
Table-3 compares our findings to the reported spectrum 
of glomerular diseases in other Iraqi centers at different 
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time. FSGS topped the list in all the studies except in 
Mahassin study where MesPGN was the commonest 
lesion. MCD and MesPGN were more frequent in the 
period 1986-1996, while FSGS was predominant during 
the period 1994-2012.
Table-4 compares our findings to the reported prevalence 
of glomerular lesions in different countries. MCD is more 
prevalent in north and south African countries except in 
Ghana where FSGS is predominant. In Saudi Arabia, 
India, Singapore, Hong Kong and the United Kingdom, 
MCD is predominant. In Iraq, FSGS is predominant.
Of the studied 58 cases, IF examination was done in 56 
cases while in two cases no specimen was available for 
IF. Among those 56 cases, 21 biopsies (37.5%) were IF 
positive and 35 biopsies (62.5%) were negative. Table-5 
shows the frequency of immune deposits in studied 
cases.
Among 12 cases of MCD, one showed mild increased 
cellularity and matrix in the mesangium by LM and 
mesangial deposits of C3 and C1q in IF. The remaining 
11 cases were normal in IF and LM. MGN was diagnosed 
in 8 cases with IgG and C3 deposition in all and C1q 
deposition in two of them. In two cases (3.45%) specimens 
fulfilled clinical, morphological and immunofluorescent 
criteria for LN. The predominant deposits in IF of LN 
were C3 and IgG followed by C1q and fibrin in the 
crescents of one case (Figures 1-2). Deposits of IgG in 
a smooth, diffuse, linear pattern were found in a patient 
who had superimposition of anti-GBM disease on pre-
existing MGN (Figure-3).One case of renal allograft 
specimen showed C4d deposits and was diagnosed as 
acute transplant rejection. 


























    Total
AKF 0 0 0 1 0 1 0 0 1 0 0 5.2 %
Nephrotic syndrome 4 1 8 2 2 4 3 8 12 0 0 75.9 %
Proteinuria 2 0 8 1 0 3 3 8 12 0 0 62.1 %
Hematuria 2 1 0 1 2 0 0 0 0 0 0 10.3 %
SLE 0 0 0 1 0 0 0 0 1 0 0 3.4 %
Nephritic syndrome 2 1 0 1 0 1 0 0 0 0 0 10.3 %
Anemia 2 1 0 2 1 1 1 0 2 0 0 17.2 %
Hypertension 3 2 4 2 1 3 2 1 0 0 1 32.8 %
CKF 1 0 2 1 0 1 1 0 1 1 2 17.2 %
ARF: acute kidney failure; SLE: systemic lupus erythematosus; CKF:chronic kidney failure; MesPN: mesangio-proliferative glomerulonephritis; HNS: 
hypertensive nephrosclerosis; MGN: membranous glomerulonephritis; LN: lupus nephritis; IgAN: IgA nephropathy; GGS: global glomerulosclerosis; 
Am: amyloidosis; MCD: minimal change disease; FSGS: focal segmental glomerulosclerosis; TR: transplant rejection; IGN: immune glomerulonephri-
tis; ANCA: antineutrophil cytoplasmic antibody.
Table 2: Histopathological diagnoses of the studied 58 renal 
biopsy specimens
Diagnosis Number 
Focal segmental glomerulosclerosis 17 (29.3 %) 
Minimal change disease 12 (20.7 %) 
Membranous GN   8 (13.8 %)
Global glomerulosclerosis 5 (8.6 %)
Mesangio-proliferative GN 4 (6.9 %)
Amyloidosis 3 (5.2 %)
Hypertensive nephrosclerosis 2 (3.5 %)
Lupus nephritis 2 (3.5 %)
IgA Nephropathy 2 (3.5 %)
Immune glomerulonephritis (ANCA +ve) 2 (3.5 %)
Transplant rejection 2 (1.7 %)
GN: glomerulonephritis; ANCA: antineutrophil cytoplasmic antibody.
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Table 3: Reported spectrum of glomerular diseases in different Iraqi studies [13]
Study 
period
Primary glomerular disease Secondary glomerular disease




































































































0 0 0 0
*Five patients with global glomerulosclerosis (GGS) were excluded in this table.
GN: glomerulonephritis; FSGS: focal segmental glomerulosclerosis; MesPGN: mesangio-proliferative GN; MCD: minimal change disease; MPGN: 
membrano-proliferative GN; MGN: membranous GN; RPGN: rapidly progressive GN; LN: lupus nephritis; Am: amyloidosis; DM: diabetes mellitus; 
HDN: hereditary GN; HNS: hypertensive nephrosclerosis; IgAN: IgA nephropathy; TR: transplant rejection.
Table 4: Reported prevalence of glomerular diseases among different countries [1, 2, 8, 9, 13, 14]
country Number MCD FSGS MPGN MGN PGN
Tunesia 304  49 (16%) 49 (16%) 51 (16.8%) 64 (21%) 91 (30%)
Sudan 40 7 (18%) 5 (13%) 0 13 (33%) 15 (38%)
Saudi Arabia 272 83 (31%) 30 (11%) 22 (8%) 16 (6%) 63 (23%)
United kingdom 272 83 (31%) 30 (11%) 47 (17.3%) 69 (25.4%) 43 (19.4%)
South Africa (black) 252 27 (10.7%) 9 (3.8%) 90 (35.7%) 54 (21.4%) 72 (28.6%)
South Africa (indian) 75 16 (21.3%) 3 (4.0%) 10 (13.3%) 16 (21.3%) 30 (40%)
India 98 28 (29%) 0 16 (16%) 16 (16%) 38 (39%)
Malaysia 866 42 (4.8%) 54 (6.5%) 24 (2.8%) 69 (8%) 306 (35.3%)
Singapore 607 190 (31.3%) 66 (10.9%) 14 (2.3%) 21 (3.5%) 316 (52%)
Hong Kong 271 75 (27.7%) 64 (23.6%) 29 (10.7%) 44 (16.2%) 59 (21.8)
Ghana 31 3 (10%) 11 (36%) 4 (13%) 5 (16%) 8 (25%)
Iraq (1986 -2001) 1047 173 (16.5%) 195 (18.6%) 150 (14.3%) 145 (13.8%) 240 (22.9%)
Iraq (2010-2012)* 58 12 (20.7%) 17 (29.31%) 0 8 (13.80%) 11 (18%)†
* Present study.
† 41 patients in our study had secondary GN and we excluded diabetic patients.
GN: glomerulonephritis; MCD: minimal change disease; FSGS: focal segmental glomerulosclerosis; MPGN: membrano-proliferative GN ; MGN: 
membranous GN; PGN: primary GN.
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Discussion
Since glomerulonephritidis are immunologically 
mediated, IF microscopy is helpful in the diagnosis of 
glomerular diseases. Yet, combined analysis of LM 
and IF findings together with correlation of clinical, 
biochemical and serological features are essential for 
accurate diagnosis. 
In this study of 58 cases, FSGS (29.3 %) was the 
commonest pattern of glomerulonephritis followed by 
MCD. There is a great variation regarding the pattern of 
GN in different countries. Nevertheless, the present study 
has similarities with many other studies (Table-4) [1, 2, 8, 
9, 13, 14]. This difference in the spectrum of gloemerular 
diseases may be attributed to the lack of IF examination 
of renal biopsies in some of these studies. Diagnosis 
of MCD is usually made by the absence of glomerular 
alteration in LM and lack of immune deposits in IF [15]. 
Minor degrees of mesangial matrix increment and/or 
hyper cellularity also form an integral part of MCD [15, 
16]. When these feature are more marked, it becomes 
difficult to segregate MCD from MesPGN [16, 17].
Linear deposit of IG at the GBM and demonstration of 
anti-GBM antibody in the serum are the typical characters 
of anti-GBM disease [18, 19]. The reason for linear 
deposition of IgG and C3 along GBM and IgG deposition 
in the mesangium observed in one of our patient is due 
to superimposition of anti-GBM disease on pre-existing 
MGN. The predominant immune deposits in MesPGN 
were IgG and C3 in the mesangium and along the GBM; 
similar findings were also observed by other studies [7, 
8, 19, 20].
In our study we found five patients with positive 
deposition of C1q complement component in the 
glomerular basement membrane in addition to IgG, 
kappa and lamda light chains and C3. One patient had 
mesangial deposition (3+) without glomerular basement 
membrane deposition; she was a 21 year old female with 
histopathological findings of FSGS in light microscopy 
and negative serology for SLE. Electron microscopy was 
not feasible for this patient and she was treated as primary 
C1q nephropathy with cyclosporine A and showed good 
clinical response. This is consistent with Jennette and 
Hipp who first proposed that C1q nephropathy was a 
distinct clinical entity that caused GN in the absence 
of SLE with deposition of C1q predominantly in the 
mesangial area [21, 22]. In these early reports, C1q 
nephropathy had specific histopathological patterns of 
mainly focal or diffuse mesPGN. Several patterns have 
subsequently been reported in renal biopsies, ranging 
from minor glomerular abnormalities or mesPGN to 
focal glomerulosclerosis. Most recent reports describe 
Table 5: Immunofluorescence findings in the studied 56 renal biopsy specimens
Disease Fibrin IgG IgM IgA C1q C3 Kappa LC Lambda LC
MesPGN (n=4) 0 4 0 0 1 2 1 1
HNS (n=2) 0 0 0 0 0 0 0 0
MGN (n=8) 0 8 0 0 2 8 0 0
LN (n=2) 1 2 0 0 1 2 2 2
IgAN (n=2) 0 0 0 2 0 1 1 1
GGS (n=5) 0 0 0 0 0 0 0 0
Am (n=3) 0 0 0 0 0 0 0 0
MCD (n=12) 0 1 1 0 0 1 0 0
FSGS (n=17) 0 2 0 0 1 2 0 0
TR (n=1) 0 0 0 0 0 0* 0 0
IGN-ANCA+ve (n=2) 0 2 0 0 1 2 2 2
Total 1 20 1 2 6 18 6 6
* C4d positive.
GN: glomerulonephritis; MesPGN: mesangio-proliferative GN; HNS: hypertensive nephrosclerosis; MGN: membranous GN; LN: lupus nephritis; 
IgAN: IgA Nephropathy; GGS: global glomerulosclerosis; Am: amyloidosis; MCD: minimal change disease; FSGS: focal segmental glomerulosclerosis; 
TR: transplant rejection; IGN: immune GN; ANCA: antineutrophil cytoplasmic antibody; LC: light chain.
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C1q nephropathy of the focal glomerulo sclerosis type 
[22]. All other four patients with positive C1q had 
positive serological markers for SLE and three of them 
progressed to chronic kidney failure.
Using IF staining in all but two of our patients may explain 
the different spectrum of glomerular lesions seen in our 
study when compared with other Iraqi studies in which 
no IF staining was used. The use of IF also explains the 
difference in the prevalence of FSGS in our study when 
compared with other studies in different countries where 
MCD was predominant. 
Conclusions
FSGS was the commonest GN  in this cohort of adult 
patients and nephrotic syndrome was the predominant 
clinical presentation. Using IF technique and correlating 
it with LM together with clinical, biochemical and 
serological markers should be done on a regular basis for 
correct diagnosis of glomerular diseases. 
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